A recurrent pathogenic BRCA2 exon 5–11 duplication in the Christian Arab population in Israel

[1]  E. Friedman,et al.  The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients , 2019, Breast Cancer Research and Treatment.

[2]  A. Shuldiner,et al.  Homozygosity for CHEK2 p.Gly167Arg leads to a unique cancer syndrome with multiple complex chromosomal translocations in peripheral blood karyotype , 2019, Journal of Medical Genetics.

[3]  F. Mancuso,et al.  Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings , 2018, Journal of Cancer Research and Clinical Oncology.

[4]  A. Vral,et al.  Thorough in silico and in vitro cDNA analysis of 21 putative BRCA1 and BRCA2 splice variants and a complex tandem duplication in BRCA2 allowing the identification of activated cryptic splice donor sites in BRCA2 exon 11 , 2018, Human mutation.

[5]  C. Gray,et al.  PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials. , 2018, Current drug targets.

[6]  E. Friedman,et al.  Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel , 2017, Breast Cancer Research and Treatment.

[7]  W. Chung,et al.  Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers , 2017, JAMA.

[8]  D. Amadori,et al.  Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer , 2017, Oncotarget.

[9]  F. Nielsen,et al.  Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer , 2016, Breast Cancer Research and Treatment.

[10]  Lara E Sucheston-Campbell,et al.  Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  E. Friedman,et al.  Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel , 2015, Breast Cancer Research and Treatment.

[12]  Á. Carracedo,et al.  RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families , 2014, Breast Cancer Research and Treatment.

[13]  K. Offit,et al.  Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families , 2014, Breast Cancer Research and Treatment.

[14]  R. Rouzier,et al.  Germline RAD51C mutations in ovarian cancer susceptibility , 2013, Clinical genetics.

[15]  M. King,et al.  Response to DNA damage of CHEK2 missense mutations in familial breast cancer. , 2012, Human molecular genetics.

[16]  S. Seal,et al.  Germline RAD51C mutations confer susceptibility to ovarian cancer , 2012, Nature Genetics.

[17]  J. Benítez,et al.  Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families. , 2012, Human molecular genetics.

[18]  M. Khayat,et al.  High carriers frequency of an apparently ancient founder mutation p.Tyr322X in the ERCC8 gene responsible for Cockayne syndrome among Christian Arabs in Northern Israel , 2010, American journal of medical genetics. Part A.

[19]  J. Tolmie,et al.  Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome , 2010, Human mutation.

[20]  T. Rebbeck,et al.  The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families. , 2008, Cancer research.

[21]  Francesco Sardanelli,et al.  Management of an inherited predisposition to breast cancer. , 2007, The New England journal of medicine.

[22]  D. Bercovich,et al.  A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer , 2007, BMC Cancer.

[23]  E. Jabs,et al.  Revisiting the craniosynostosis-radial ray hypoplasia association: Baller-Gerold syndrome caused by mutations in the RECQL4 gene , 2005, Journal of Medical Genetics.